Across hundreds of published papers, CBER’s new chief has argued for more stringent measures of assessing drugs for cancer ...

Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments regarding the government response to the COVID-19 pandemic.